Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000184169
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-VATC |
QB02BD06
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-ATC |
B02BD10
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-ATC |
B02BD06
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
NCI_THESAURUS |
C78311
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
VONCENTO (AUTHORIZED: HEMOPHILIA A)
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
FDA ORPHAN DRUG |
424814
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
||
|
WHO-VATC |
QB02BD10
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
D014841
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
C81465
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
100000090387
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
11274
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
ALTERNATIVE | RxNorm | ||
|
N0000175979
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Increased Coagulation Activity [PE] | ||
|
SUB72116
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
826072
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
109319-16-6
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
GENERIC (FAMILY) | |||
|
ZE22NE22F1
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
Von Willebrand Factor
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
DB13133
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
N0000009524
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Increased Platelet Aggregation [PE] | ||
|
N0000007914
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
ZE22NE22F1
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | |||
|
N0000171498
Created by
admin on Mon Mar 31 20:31:54 GMT 2025 , Edited by admin on Mon Mar 31 20:31:54 GMT 2025
|
PRIMARY | von Willebrand Factor [Chemical/Ingredient] |
ACTIVE MOIETY
